Incorporating risk preferences of patients in the valuation of immune checkpoint inhibitors for non-small cell lung cancer

Immunotherapy offers a distinctive mechanism of action compared to traditional treatments, arising from additional value dimensions that may not be captured in standard health technology assessments. Cancer patients may have the expectation that immunotherapy provides durable, long-term survival gai...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaim, Remziye, Redekop, W. Ken, Uyl-de Groot, Carin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032401/
https://www.ncbi.nlm.nih.gov/pubmed/36969040
http://dx.doi.org/10.3389/fonc.2023.1027659

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10032401/
https://www.ncbi.nlm.nih.gov/pubmed/36969040
http://dx.doi.org/10.3389/fonc.2023.1027659

Ejemplares similares